Policy and Return on Investment Scenario Model (PRISM™)

PRISM™ allows our clients to develop quantitative evidence to demonstrate the value of investing in factors which prevent ill health (rather than treat illness) which is an increasing focus of many healthcare systems. The approach can be tailored to different public health and policy scenarios, such as investment in adult and/or pediatric vaccination programmes, smoking cessation programmes, and other health and wellness campaigns aimed at preventing ill health.
Understanding the economic return for every £, $ or € invested
Determining the break-even point at which savings from prevented illness meets the cost of implementing the strategy
The number of QALYs or life years gained, and disease cases, deaths or other factors averted through investment in the chosen strategy
View a case study on a previous PRISM™ project
Immunisation Return on
Investment Model
Health Economics & Data Analysis
Click here for details of our wider expertise and our database of published research and conference presentations